Improving Malaria Control in West Africa: Interruption of Transmission As a Paradigm Shift

With the paradigm shift from the reduction of morbidity and mortality to the interruption of transmission, the focus of malaria control broadens from symptomatic infections in children ≤5 years of age to include asymptomatic infections in older children and adults. In addition, as control efforts intensify and the number of interventions increases, there will be decreases in prevalence, incidence and transmission with additional decreases in morbidity and mortality. Expected secondary consequences of these changes include upward shifts in the peak ages for infection (parasitemia) and disease, increases in the ages for acquisition of antiparasite humoral and cellular immune responses and increases in false-negative blood smears and rapid diagnostic tests. Strategies to monitor these changes must include: (1) studies of the entire population (that are not restricted to children ≤5 or ≤10 years of age), (2) study sites in both cities and rural areas (because of increasing urbanization across sub-Saharan Africa) and (3) innovative strategies for surveillance as the prevalence of infection decreases and the frequency of false-negative smears and rapid diagnostic tests increases.

Citing Articles

A Decade of Progress Accelerating Malaria Control in Mali: Evidence from the West Africa International Center of Excellence for Malaria Research.

Doumbia S, Sogoba N, Diakite M, Toure M, Keita M, Konate D Am J Trop Med Hyg. 2022; 107(4_Suppl):75-83.

PMID: 36228923 PMC: 9662231. DOI: 10.4269/ajtmh.21-1309.

The West Africa ICEMR Partnerships for Guiding Policy to Improve the Malaria Prevention and Control.

Doumbia S, Toure M, Sogoba N, Alifrangis M, Diakite M, Diarra A Am J Trop Med Hyg. 2022; 107(4_Suppl):84-89.

PMID: 36228908 PMC: 9662222. DOI: 10.4269/ajtmh.21-1330.

Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali.

Shaffer J, Mather F, Wele M, Li J, Tangara C, Kassogue Y Front Genet. 2019; 10:331.

PMID: 31031807 PMC: 6473184. DOI: 10.3389/fgene.2019.00331.

Development of a data collection and management system in West Africa: challenges and sustainability.

Shaffer J, Doumbia S, Ndiaye D, Diarra A, Gomis J, Nwakanma D Infect Dis Poverty. 2018; 7(1):125.

PMID: 30541626 PMC: 6292095. DOI: 10.1186/s40249-018-0494-4.

Urban Malaria: Understanding its Epidemiology, Ecology, and Transmission Across Seven Diverse ICEMR Network Sites.

Wilson M, Krogstad D, Arinaitwe E, Arevalo-Herrera M, Chery L, Ferreira M Am J Trop Med Hyg. 2015; 93(3 Suppl):110-123.

PMID: 26259941 PMC: 4574269. DOI: 10.4269/ajtmh.14-0834.

References

Smith H, Bukirwa H, Mukasa O, Snell P, Adeh-Nsoh S, Mbuyita S . Access to electronic health knowledge in five countries in Africa: a descriptive study. BMC Health Serv Res. 2007; 7:72. PMC: 1885254. DOI: 10.1186/1472-6963-7-72. View

Bates A, Mu J, Jiang H, Fairhurst R, Su X . Use of magnetically purified Plasmodium falciparum parasites improves the accuracy of erythrocyte invasion assays. Exp Parasitol. 2010; 126(2):278-80. PMC: 2940115. DOI: 10.1016/j.exppara.2010.05.007. View

Griffing S, Mixson-Hayden T, Sridaran S, Alam M, McCollum A, Cabezas C . South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS One. 2011; 6(9):e23486. PMC: 3174945. DOI: 10.1371/journal.pone.0023486. View

Cholera R, Brittain N, Gillrie M, Lopera-Mesa T, Diakite S, Arie T . Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc Natl Acad Sci U S A. 2008; 105(3):991-6. PMC: 2242681. DOI: 10.1073/pnas.0711401105. View

Atieli F, Munga S, Ofulla A, Vulule J . The effect of repeated washing of long-lasting insecticide-treated nets (LLINs) on the feeding success and survival rates of Anopheles gambiae. Malar J. 2010; 9:304. PMC: 2988039. DOI: 10.1186/1475-2875-9-304. View

Ceesay S, Casals-Pascual C, Erskine J, Anya S, Duah N, Fulford A . Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008; 372(9649):1545-54. PMC: 2607025. DOI: 10.1016/S0140-6736(08)61654-2. View

Satoguina J, Walther B, Drakeley C, Nwakanma D, Oriero E, Correa S . Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J. 2009; 8:274. PMC: 2791766. DOI: 10.1186/1475-2875-8-274. View

Ndiaye D, Patel V, Demas A, LeRoux M, Ndir O, Mboup S . A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in Senegal. Am J Trop Med Hyg. 2010; 82(2):228-30. PMC: 2813162. DOI: 10.4269/ajtmh.2010.09-0470. View

Bojang K, Milligan P, Pinder M, Doherty T, Leach A, Ofori-Anyinam O . Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia. Hum Vaccin. 2009; 5(4):242-7. PMC: 3787299. DOI: 10.4161/hv.5.4.7050. View

10.

Greenwood B . Can malaria be eliminated?. Trans R Soc Trop Med Hyg. 2008; 103 Suppl 1:S2-5. DOI: 10.1016/j.trstmh.2008.10.027. View

11.

Cohen J, Moonen B, Snow R, Smith D . How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J. 2010; 9:213. PMC: 2983111. DOI: 10.1186/1475-2875-9-213. View

12.

Nahlen B, Low-Beer D . Building to collective impact: the Global Fund support for measuring reduction in the burden of malaria. Am J Trop Med Hyg. 2008; 77(6 Suppl):321-7. View

13.

Biggs B, Kemp D, Brown G . Subtelomeric chromosome deletions in field isolates of Plasmodium falciparum and their relationship to loss of cytoadherence in vitro. Proc Natl Acad Sci U S A. 1989; 86(7):2428-32. PMC: 286926. DOI: 10.1073/pnas.86.7.2428. View

14.

Ndiaye J, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B . Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J. 2009; 8:125. PMC: 2698916. DOI: 10.1186/1475-2875-8-125. View

15.

Walther M, Jeffries D, Finney O, Njie M, Ebonyi A, Deininger S . Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009; 5(4):e1000364. PMC: 2658808. DOI: 10.1371/journal.ppat.1000364. View

16.

Prudhomme OMeara W, Mangeni J, Steketee R, Greenwood B . Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010; 10(8):545-55. DOI: 10.1016/S1473-3099(10)70096-7. View

17.

Rowe A . Potential of integrated continuous surveys and quality management to support monitoring, evaluation, and the scale-up of health interventions in developing countries. Am J Trop Med Hyg. 2009; 80(6):971-9. View

18.

Pologe L, Ravetch J . A chromosomal rearrangement in a P. falciparum histidine-rich protein gene is associated with the knobless phenotype. Nature. 1986; 322(6078):474-7. DOI: 10.1038/322474a0. View

19.

Bountogo M, Zoungrana A, Coulibaly B, Klose C, Mansmann U, Mockenhaupt F . Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso. Trop Med Int Health. 2010; 15(6):713-7. DOI: 10.1111/j.1365-3156.2010.02526.x. View

20.

Miura K, Orcutt A, Muratova O, Miller L, Saul A, Long C . Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine. 2007; 26(2):193-200. PMC: 2253722. DOI: 10.1016/j.vaccine.2007.10.064. View